The 30^th European Academy of Dermatology and Venereology (EADV) Congress was held virtually from 29^th September to 2^nd October.

In this special anniversary edition, Bella Aurora, which specializes in the study of melanocyte behaviour,  presented at a symposium to the international scientific community, its latest product: Repigment12. The cosmetic treatment that mitigates the aesthetic consequences of vitiligo.

The symposium took place on 29 September at 11:30 and was attended by Dr. Matteo Bordignon, an Italian dermatologist specialising in the treatment of vitiligo and the creator of Repigment12, along with Bella Aurora.The symposium will also be attended by Spanish dermatologist Dr. Agustín Alomar, who has been studying this skin disease for more than 30 years.

Bella Aurora Labs was represented by Medical Advisor Marta Bajona, who exhibited a scientific poster with the results of the trial led by Dr.Bordignon, proving the efficacy of Repigment12.

For more information on EADV: https://www.eadvcongress2021.org/